CD4 and type 2 diabetes mellitus: There is also evidence that poorly controlled HbA1c (HbA1c 1-year mean > 7%) following SARS-CoV-2 vaccination in a cohort of patients with type 2 diabetes is associated with a reduced cytokine response from CD4+ T cells and increased incidence of breakthrough infections [51].